• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.

作者信息

Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J, Ueno N, Giralt S, Anderlini P

机构信息

Department of Blood and Marrow Transplantation, University of Texas-MD Anderson Cancer Center, Houston 77030, USA.

出版信息

Br J Haematol. 2000 Oct;111(1):18-29. doi: 10.1046/j.1365-2141.2000.02196.x.

DOI:10.1046/j.1365-2141.2000.02196.x
PMID:11091179
Abstract
摘要

相似文献

1
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.利用移植物抗恶性肿瘤作用：异基因造血移植的非清髓性预处理方案，一种不断发展的过继性免疫治疗策略。
Br J Haematol. 2000 Oct;111(1):18-29. doi: 10.1046/j.1365-2141.2000.02196.x.
2
Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions.异基因骨髓移植和异基因供体白细胞输注的移植物抗白血病及移植物抗淋巴瘤效应。
Ann Hematol. 1995 Nov;71(5):209-17. doi: 10.1007/BF01744370.
3
The Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-host.莫蒂默·M·博廷讲座：通过免疫反应进行破坏：探寻移植物抗白血病与移植物抗宿主反应的分离
Biol Blood Marrow Transplant. 2004 Aug;10(8):505-23. doi: 10.1016/j.bbmt.2004.05.005.
4
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.Th2细胞和Tc2细胞在移植物抗宿主病、移植物抗白血病效应及移植物排斥反应调控中的作用：白血病和淋巴瘤异基因移植治疗的思考
Leuk Lymphoma. 2000 Jul;38(3-4):221-34. doi: 10.3109/10428190009087014.
5
How low can the doses go? Transplanters look to less toxic future.剂量能降低到多少？移植专家期待毒性更低的未来。
J Natl Cancer Inst. 2000 Aug 16;92(16):1284-7. doi: 10.1093/jnci/92.16.1284.
6
[Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].[异基因造血干细胞移植治疗血液系统恶性肿瘤]
Bull Cancer. 2001 Sep;88(9):908-26.
7
[Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy].[异基因造血干细胞移植（HSCT）后同种异体反应性供体淋巴细胞（DLI）：毒性和疗效研究]
Bull Cancer. 2003 Aug-Sep;90(8-9):758-62.
8
Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.在B细胞白血病/淋巴瘤小鼠模型中，T细胞去除的异基因骨髓移植后，不依赖移植物抗宿主病的有效移植物抗白血病效应。细胞疗法和重组白细胞介素-2的作用
J Immunol. 1994 Sep 15;153(6):2562-7.
9
Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?异基因骨髓细胞移植后进行主动免疫接种：癌症免疫治疗的一种新选择？
Arch Immunol Ther Exp (Warsz). 2002;50(3):197-224.
10
The graft-versus-leukemia effects of allogeneic cell therapy.
Annu Rev Med. 1999;50:369-86. doi: 10.1146/annurev.med.50.1.369.

引用本文的文献

1
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD Prophylaxis.预处理强度对接受抗胸腺细胞球蛋白和基于移植后环磷酰胺的移植物抗宿主病预防的急性髓系白血病成年患者（<65岁）生存的影响
Eur J Haematol. 2025 Sep;115(3):251-259. doi: 10.1111/ejh.14438. Epub 2025 May 28.
2
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial.异基因造血干细胞移植后限时与标准疗程免疫抑制：前瞻性随机HOVON-96试验结果
Hemasphere. 2024 Dec 11;8(12):e70040. doi: 10.1002/hem3.70040. eCollection 2024 Dec.
3
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.在首次完全缓解期接受移植的微小残留病阴性但非微小残留病阳性的急性淋巴细胞白血病患者中，8格雷和12格雷全脑照射联合氟达拉滨及移植后环磷酰胺的疗效相当。
Eur J Haematol. 2025 Jan;114(1):79-88. doi: 10.1111/ejh.14305. Epub 2024 Sep 19.
4
Implementation of Routine Endoscopy with Narrow Band Imaging in the Evaluation of Oral and Upper Airways Lesions in Oral Chronic Graft-Versus-Host Disease: A Preliminary Study.窄带成像技术在口腔慢性移植物抗宿主病口腔及上气道病变评估中的常规内镜应用：一项初步研究
J Pers Med. 2022 Oct 1;12(10):1628. doi: 10.3390/jpm12101628.
5
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial.异基因干细胞移植前基于曲奥舒凡的预处理方案：一项2期临床试验的长期结果
Front Oncol. 2021 Sep 10;11:731478. doi: 10.3389/fonc.2021.731478. eCollection 2021.
6
Clostridioides difficile Infections in Inpatient Pediatric Oncology Patients: A Cohort Study Evaluating Risk Factors and Associated Outcomes.艰难梭菌感染在住院儿科肿瘤患者中的队列研究：评估危险因素及相关结局。
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):302-308. doi: 10.1093/jpids/piaa090.
7
Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a single-center experience.102例血液系统恶性肿瘤患儿单倍体造血干细胞移植的肿瘤消融预处理方案：单中心经验
Oncotarget. 2017 Dec 4;8(69):113749-113757. doi: 10.18632/oncotarget.22893. eCollection 2017 Dec 26.
8
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes.骨髓增生异常综合征的疾病特征而非供体来源，可预测造血干细胞移植的结果。
Bone Marrow Transplant. 2017 Apr;52(4):532-538. doi: 10.1038/bmt.2016.303. Epub 2016 Dec 12.
9
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation.与减低强度预处理相比，采用清髓性预处理进行 HLA 配型相合的同胞异基因干细胞移植治疗急性髓系白血病后的长期生存及晚期事件：代表欧洲血液与骨髓移植组急性白血病工作组的报告
J Hematol Oncol. 2016 Nov 8;9(1):118. doi: 10.1186/s13045-016-0347-1.
10
Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.突破极限——异基因造血移植的非清髓性和减低强度预处理方案
Bone Marrow Transplant. 2015 Sep;50(9):1157-67. doi: 10.1038/bmt.2015.61. Epub 2015 May 18.